Similar articles

• Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine.

  Hamilton DV, Carmichael DJ, Evans DB, Calne RY. Hamilton DV, et al. Transplant Proc. 1982 Sep;14(3):597-600. Transplant Proc. 1982. PMID: 6758243 No abstract available.
• Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.

  Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD. Lorber MI, et al. Transplant Proc. 1985 Aug;17(4 Suppl 1):282-5. Transplant Proc. 1985. PMID: 3895668 No abstract available.
• The frequency and significance of thiopurine S-methyltransferase gene polymorphisms in azathioprine-treated renal transplant recipients.

  Moloney FJ, Dicker P, Conlon PJ, Shields DC, Murphy GM. Moloney FJ, et al. Br J Dermatol. 2006 Jun;154(6):1199-200. doi: 10.1111/j.1365-2133.2006.07239.x. Br J Dermatol. 2006. PMID: 16704656 No abstract available.
• A case of disseminated superficial actinic porokeratosis subsequent to renal transplantation.

  Matsushita S, Kanekura T, Kanzaki T. Matsushita S, et al. J Dermatol. 1997 Feb;24(2):110-2. J Dermatol. 1997. PMID: 9065706 Review.
• [Myelodysplastic syndrome (RAEB in T) developed in a renal allograft recipient].

  Shiraishi J, Sudo Y, Katori Y, Akiyama M, Takada O, Maki K, Sawada K, Inaba T, Shimazaki C, Nakagawa M. Shiraishi J, et al. Rinsho Ketsueki. 1998 Aug;39(8):600-5. Rinsho Ketsueki. 1998. PMID: 9785979 Review. Japanese.